Risk factors and a new nomogram for glioblastoma: based on a retrospective study
We present a validated, blood-based nomogram for GBM risk prediction with high discriminative power. This model may aid clinicians in early identification and personalized management of high-risk individuals.
Authors
- Chengliang Mao
- Congying Zheng (ORCID: https://orcid.org/0000-0002-6758-0930)
- Bo Wu (ORCID: https://orcid.org/0000-0003-4332-5190)
Institutions
- Chongqing University (CN)
- Guangdong Academy of Medical Sciences (CN)
- First People's Hospital of Chongqing (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-08-29
- DOI
- https://doi.org/10.3389/fimmu.2025.1642107
- Citations
- 1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.63